F10 and neoplasm: Of note, myeloid cells have also been described to themselves generate and secrete FX/FXa, with rivaroxaban reported to exhibit antitumor immunity by blocking the FXa–PAR-2 pathway, leading to the reprograming of tumor-associated macrophages [22, 48].